Pille Harrison

发表

Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls

Jake K. Byrnes, Tomas W. Fitzgerald, P. Donnelly, 2010, Nature.

Genome-wide association study of copy number variation in 16,000 cases of eight common diseases and 3,000 shared controls

Jake K. Byrnes, Tomas W. Fitzgerald, Renwick, 2010 .

Rheumatoid arthritis association at 6q23

D. Strachan, A. Barton, I. Bruce, 2007, Nature Genetics.

Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci

Jing Cui, Kristin G Ardlie, B Paul Wordsworth, 2010, Nature Genetics.

Overlapping genetic susceptibility variants between three autoimmune disorders: rheumatoid arthritis, type 1 diabetes and coeliac disease

Edward Flynn, John Bowes, Wendy Thomson, 2010, Arthritis research & therapy.

Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial

S. Schreiber, S. Vermeire, Pille Harrison, 2017, The Lancet.

Cardiorespiratory responses of patients with rheumatoid arthritis during bicycle riding and running in water.

Pille Harrison, J. Walter, S. Melton-Rogers, 1996, Physical therapy.

Extended Report

Xiayi Ke, Edward Flynn, Wendy Thomson, 2022 .

PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population

John Bowes, Wendy Thomson, Anne Barton, 2009, Annals of the rheumatic diseases.

Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13

Xiayi Ke, Paul Wordsworth, John Bowes, 2008, Nature Genetics.

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial

L. Coates, D. Gladman, Pille Harrison, 2018, The Lancet.

Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2)

J. Kremer, Pille Harrison, A. Kavanaugh, 2016, Annals of the rheumatic diseases.

Porcine platelets contain an increased quantity of ultra‐high molecular weight von Willebrand factor and numerous alpha‐granular tubular structures

Pille Harrison, G. Savidge, E. Cramer, 1993, British journal of haematology.

Unique expression of von Willebrand factor by type IIA von Willebrand's disease endothelial cells

Pille Harrison, D. Bevan, G. Savidge, 1992, British journal of haematology.

Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions.

Pille Harrison, J. Desrivot, A. Van der Aa, 2016, Drug metabolism letters.

Increased circulating platelet–leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis

D. Isenberg, Pille Harrison, I. Mackie, 2001, British journal of haematology.

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis: results from a randomised, placebo-controlled, phase 2 trial (EQUATOR)

L. Coates, D. Gladman, Pille Harrison, 2019 .

Studies of multimerin in patients with von Willebrand disease and platelet von Willebrand factor deficiency

Pille Harrison, P. Mannucci, A. Federici, 1998, British journal of haematology.

Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.

Pille Harrison, G. Hughes, S. Sangle, 2004, Rheumatology.

Platelet-rich plasma injection for acute Achilles tendon rupture

K. Willett, Pille Harrison, P. Hulley, 2022, The bone & joint journal.

Comparison of glycocalicin, thrombopoietin and reticulated platelet measurement as markers of platelet turnover in HIV+ samples

Pille Harrison, I. Mackie, S. Machin, 2001, Platelets.

Effects of PTPN22 C1858T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients.

C. Farrar, M. Brown, Pille Harrison, 2006, Rheumatology.

Evidence of cis-acting regulatory variation in PTPN22 in patients with rheumatoid arthritis

Pille Harrison, Jennifer J. Pointon, L. Southam, 2012, Scandinavian journal of rheumatology.

Bioloogiliste ravimite uus julge maailm: ravimiarenduse edasiminekud viimase viie aasta jooksul

Pille Harrison, A. Irs, Ott Laius, 2011 .

Confirmation of association of the REL locus with rheumatoid arthritis susceptibility in the UK population

A. Barton, S. Eyre, A. Hinks, 2009, Annals of the rheumatic diseases.

No evidence for association of the KLF12 gene with rheumatoid arthritis in a large UK cohort

A. Barton, S. Eyre, A. Hinks, 2009, Annals of the rheumatic diseases.

Association of CD40 with rheumatoid arthritis confirmed in a large UK case-control study

A. Barton, S. Eyre, A. Hinks, 2009, Annals of the rheumatic diseases.

Combined effects of three independent SNPs greatly increase the risk estimate for RA at 6q23

A. Barton, S. Eyre, A. Hinks, 2009, Human molecular genetics.

Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes

A. Barton, S. Eyre, A. Hinks, 2009, Human molecular genetics.

Re-evaluation of putative rheumatoid arthritis susceptibility genes in the post-genome wide association study era and hypothesis of a key pathway underlying susceptibility

Ann Morgan, Xiayi Ke, Paul Wordsworth, 2008, Human molecular genetics.

Genetic variants at CD28, PRDM1, and CD2/CD58 are associated with rheumatoid arthritis risk

M. Daly, Annette Lee, P. Gregersen, 2009, Nature Genetics.

The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance.

Pille Harrison, P. Donaldson, R. Williams, 2000, Journal of hepatology.

Effects of PTPN 22 C 1858 T polymorphism on susceptibility and clinical characteristics of British Caucasian rheumatoid arthritis patients

C. Farrar, M. Brown, Pille Harrison, 2006 .

The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets

T. Merriman, Pille Harrison, N. Dalbeth, 2009, Arthritis research & therapy.

A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis

A. Barton, S. Eyre, A. Hinks, 2009, Annals of the rheumatic diseases.

Influence of age and renal impairment on the steady state pharmacokinetics of filgotinib, a selective JAK1 inhibitor

Pille Harrison, Liesbeth Fagard, Y. Xin, 2018, British journal of clinical pharmacology.

Ability of Platelet-Derived Extracellular Vesicles to Promote Neutrophil-Endothelial Cell Interactions

Pille Harrison, G. Nash, G. Rainger, 2018, Inflammation.

Interleukin-1 promoter region polymorphism role in rheumatoid arthritis: a meta-analysis of IL-1B-511A/G variant reveals association with rheumatoid arthritis.

A. Roddam, Pille Harrison, Jennifer J. Pointon, 2008, Rheumatology.

In vivo biotinylation studies: specificity of labelling of reticulated platelets by thiazole orange and mepacrine

Pille Harrison, I. Mackie, S. Machin, 2000, British journal of haematology.

Effect of Type IIB von Willebrand Disease Mutation Arg(545)Cys on Platelet Glycoprotein Ib Binding – Studies with Recombinant von Willebrand Factor

Pille Harrison, J. Sadler, N. Kornbrot, 1993, Thrombosis and Haemostasis.

Investigating the viability of genetic screening/testing for RA susceptibility using combinations of five confirmed risk loci

A. Barton, S. Eyre, A. Hinks, 2009, Rheumatology.

Advances in Platelet Counting

Pille Harrison, S. Machin, C. Briggs, 2001, Hematology.

Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population.

Stephen G. Martin, J. Barrett, A. Barton, 2009, Arthritis and rheumatism.

Effect of filgotinib, a selective JAK 1 inhibitor, with and without methotrexate in patients with rheumatoid arthritis: patient-reported outcomes

M. Genovese, Pille Harrison, A. Kavanaugh, 2018, Arthritis Research & Therapy.

CD14-positive extracellular vesicles in bronchoalveolar lavage fluid as a new biomarker of acute respiratory distress syndrome

Pille Harrison, D. Thickett, M. Matthay, 2021, medRxiv.

Characterization of Three Mutations Causing von Willebrand Disease Type IIA in Five Unrelated Families

Pille Harrison, I. Rabinowitz, B. Brenner, 1992, Thrombosis and Haemostasis.

Sarnased bioloogilised ravimid

Pille Harrison, A. Irs, Ott Laius, 2012 .

Filgrastiimi ja somatropiini sisaldavad sarnased bioloogilised ravimid

Pille Harrison, A. Irs, Ott Laius, 2012 .

Sarnased bioloogilised ravimid – epoetiinid

Pille Harrison, A. Irs, Ott Laius, 2012 .

No evidence for association of the systemic lupus erythematosus-associated ITGAM variant, R77H, with rheumatoid arthritis in the Caucasian population.

T. Merriman, Pille Harrison, N. Dalbeth, 2009, Rheumatology.

THU0173 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective as Monotherapy in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study

Pille Harrison, A. Kavanaugh, M. Greenwald, 2016 .

OP0224 Filgotinib (GLPG0634), An Oral Jak1 Selective Inhibitor Is Effective in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: Results from A 24-Week Phase 2B Dose Ranging Study

Pille Harrison, R. Westhovens, M. Greenwald, 2016 .

MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients.

C. Farrar, Pille Harrison, Jennifer J. Pointon, 2007, Rheumatology.

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data

Lisa, Husam, John P. Ferguson, 2023 .

Association of CD40 with rheumatoid arthritis confi rmed in a large UK case-control study

S. Eyre, A. Hinks, W. Thomson, 2010 .

Progress in the assessment of platelet function.

Pille Harrison, P. Harrison, 2000, British journal of haematology.

The expression of prion protein (PrPC) in the megakaryocyte lineage

Pille Harrison, A. Pizzey, I. Mackie, 2005, Journal of thrombosis and haemostasis : JTH.

Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors

Jones, Lisa, Marilyn, 2009 .

Increased platelet count and leucocyte–platelet complex formation in acute symptomatic compared with asymptomatic severe carotid stenosis

Paul J. Harrison, Pille Harrison, P. Sidhu, 2005, Journal of Neurology, Neurosurgery & Psychiatry.

Genetic variants at CD28, PRDM1, and CD2/CD58 are associated with rheumatoid arthritis risk

M. Daly, Annette Lee, P. Gregersen, 2009, Nature Genetics.

Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke

Pille Harrison, P. Sidhu, M. Scully, 2015, Journal of the Neurological Sciences.

Continuing developments with the automated platelet count 1

C Briggs, S J Machin, P Harrison, 2007, International journal of laboratory hematology.

Platelet activation markers and the primary antiphospholipid syndrome (PAPS)

Pille Harrison, I. Mackie, S. Machin, 1998, Lupus.

812c Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor, Induces Clinical Remission in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 2 FITZROY Study Interim Analysis

S. Vermeire, Pille Harrison, X. Hébuterne, 2016 .

University of Birmingham Relationship between ADAMTS13 activity, von Willebrand factor antigen levels and platelet function in the early and late phases after TIA or ischaemic stroke

Pille Harrison, P. Sidhu, M. Scully, 2022 .